Funding Round
Synchron Raises $200M Series D for Endovascular BCI
Business Wire11/15/2025·11/15/25🌐 USA
Summary
Synchron raised $200M in Series D funding led by Khosla Ventures for its endovascular Stentrode BCI platform that translates brain activity into digital commands for people with paralysis.
Why it matters
Synchron's $200M Series D is the largest single raise for an endovascular BCI company, validating their approach of implanting through blood vessels rather than open-brain surgery. With patients already controlling computers at home, this capital targets regulatory approval and commercial scale.
#BCI#Industry#Neural Interfaces#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in